参考文献/References:
[1] 中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志,2014,50(11):851-865.
CHINESE ACADEMY OF OPHTHALMOLOGY.Guidelines for clinical diagnosis and treatment of diabetic retinopathy in China (2014)[J].Chin J Ophthalmol,2014,50(11):851-865.
[2] KWITEROVICH K A,MAGUIRE M G,MURPHY R P,SCHACHAT A P,BRESSLER N M,BRESSLER S B,et al.Frequency of adverse systemic reactions after fluorescein angiography[J].Ophthalmology,1991,98(7):1139-1142.
[3] FINESCHI V,MONASTEROLO G,ROSI R,TURILLAZZI E.Fatal anaphylactic shock during a fluorescein angiography[J].Forensic Sci Int,1999,100(1):137-142.
[4] WANG R K,AN L,FRANCIS P,WILSON D J.Depth-resolved imaging of capillary networks in retina and choroid using ultrahigh sensitive optical microangiography[J].Opt Lett,2010,35(9):1467-1469.
[5] TAKASE N,NOZAKI M,KATO A,OZEKI H,YOSHIDA M,OGURA Y.Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography[J].Retina,2015,35(11):2377-2383.
[6] CHOI W,WAHEED N K,MOULT E M,ADHI M,LEE B,DE CARLO T,et al.Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy[J].Retina,2016,37(1):11-21.
[7] DE CARLO T E,CHIN A T,BONINI FILHO M A,ADHI M,BRANCHINI L,SALZ D A,et al.Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography[J].Retina,2015,35(11):2364-2370.
[8] LEI J,DURBIN M K,SHI Y,UJI A,BALASUBRAMANIAN S,BAGHDASARYAN E,et al.Repeatability and reproducibility of superficial macular retinal vessel density measurements using optical coherence tomography angiography en face images[J].JAMA Ophthalmol,2017,135(10):1092-1098.
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中国糖尿病杂志,2014,30(8):893-942.
Chinese Diabetes Association.Guidelines for the prevention and treatment of type 2 diabetes in China (2013 edition)[J].Chin J Diabetes,2014,30(8):893-942.
[10] PROVIS J M,SANDERCOE T,HENDRICKSON A E.Astrocytes and blood vessels define the foveal rim during primate retinal development[J].Invest Ophthalmol Vis Sci,2000,41(10):2827-2836.
[11] CRAWFORD T N,RD A D,KERRISON J B.Diabetic retinopathy and angiogenesis[J].Curr Diabetes Rev,2009,5(1):8-13.
[12] MANSOUR A M,SCHACHAT A,BODIFORD G.Foveal avascular zone in diabetes mellitus[J].Retina,1993,13(2):125-128.
[13] CONRATH J,GIORGI R,RACCAH D,RIDINGS B.Foveal avascular zone in diabetic retinopathy:quantitative vs qualitative assessment[J].Eye,2005,19(3):322-326.
[14] GILL A,COLE E D,NOVAIS E A,LOUZADA R N,DE CARLO T,DUKER J S,et al.Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography[J].Int J Retina Vitreous,2017,3:19.
[15] CARPINETO P,MASTROPASQUA R,MARCHINI G,TOTO L,DI NICOLA M,DI ANTONIO L.Reproducibility and repeatability of foveal avascular zone measurements in healthy subjects by optical coherence tomography angiography[J].Br J Ophthalmol,2016,100(5):671-676.
[16] LEI J,DURBIN M K,SHI Y,UJI A,BALASUBRAMANIAN S,BAGHDASARYAN E,et al.Repeatability and reproducibility of superficial macular retinal vessel density measurements using optical coherence tomography angiography en face images[J].JAMA Ophthalmol,2017,135(10):1092-1098.
[17] HWANG T S,GAO S S,LIU L,LAUER A K,BAILEY S T,FLAXEL C J,et al.Automated quantification of capillary nonperfusion using optical coherence tomography angiography in diabetic retinopathy[J].JAMA Ophthalmol,2016:134(4):367-373.
[18] DURBIN M K,AN L,SHEMONSKI N D,SOARES M,SANTOS T,LOPES M,et al.Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy[J].JAMA Ophthalmol,2017,135(4):370-376.
[19] BEK T.Transretinal histopathological changes in capillary-free areas of diabetic retinopathy[J].Acta Ophthalmol,1994,72(4):409-415.
相似文献/References:
[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.